Literature DB >> 11432802

Cdk5 on the brain.

D S Smith1, P L Greer, L H Tsai.   

Abstract

Mammalian brains are highly compartmentalized into groups of functionally specialized neurons. Cell migration and neurite outgrowth must be tightly orchestrated to achieve this level of organization. A small serine/threonine kinase that shows homology to cyclin-dependent kinases (Cdks) has emerged as an important regulator of neuronal migration. Cdk5, unlike other Cdks, is not regulated by cyclins, and its activity is primarily detected in postmitotic neurons in developing and adult nervous systems. This review describes work indicating that Cdk5 links extracellular signaling pathways and cytoskeletal/membrane systems to direct neuronal migration, axon growth, and possibly neurosecretion. Despite its importance, unchecked Cdk5 activity is toxic to neurons, and may underlie some of the pathologies associated with neurodegenerative disorders such as Alzheimer's disease and amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432802

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  37 in total

1.  Telling tails.

Authors:  M B Kennedy; P Manzerra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

2.  RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5.

Authors:  Yuan Xiao Zhu; Rodger Tiedemann; Chang-Xin Shi; Holly Yin; Jessica E Schmidt; Laura A Bruins; Jonathan J Keats; Esteban Braggio; Chris Sereduk; Spyro Mousses; A Keith Stewart
Journal:  Blood       Date:  2011-02-02       Impact factor: 22.113

3.  Inhibition of multiple pathways accounts for the antiapoptotic effects of flavopiridol on potassium withdrawal-induced apoptosis in neurons.

Authors:  Ester Verdaguer; Elvira G Jordà; Daniel Alvira; Andrés Jiménez; Anna Maria Canudas; Jaume Folch; Victor Rimbau; Mercè Pallàs; Antoni Camins
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Structure of the Pho85-Pho80 CDK-cyclin complex of the phosphate-responsive signal transduction pathway.

Authors:  Kexin Huang; Ian Ferrin-O'Connell; Wei Zhang; Gordon A Leonard; Erin K O'Shea; Florante A Quiocho
Journal:  Mol Cell       Date:  2007-11-30       Impact factor: 17.970

5.  New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.

Authors:  Fei Zheng; Florante A Quiocho
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

6.  The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death.

Authors:  En Huang; Dianbo Qu; Yi Zhang; Katerina Venderova; M Emdadul Haque; Maxime W C Rousseaux; Ruth S Slack; John M Woulfe; David S Park
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

7.  The CDK5 activator, p39, binds specifically to myosin essential light chain.

Authors:  Dolena R Ledee; Brajendra K Tripathi; Peggy S Zelenka
Journal:  Biochem Biophys Res Commun       Date:  2007-01-29       Impact factor: 3.575

8.  Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5.

Authors:  S D Norrholm; J A Bibb; E J Nestler; C C Ouimet; J R Taylor; P Greengard
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.

Authors:  Rani Dhavan; Paul L Greer; Maria A Morabito; Lianna R Orlando; Li-Huei Tsai
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

10.  Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5.

Authors:  Wei Wang; Xiaoning Cao; Xiaolei Zhu; Yongliang Gu
Journal:  J Mol Model       Date:  2013-03-23       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.